Works matching IS 09203206 AND DT 2025 AND VI 39 AND IP 1
Results: 25
Enhancing Glucose Uptake as a Means to Protect the Heart During Cardiopulmonary Bypass or Ischemia–Reperfusion Injury.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 15, doi. 10.1007/s10557-024-07648-z
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 13, doi. 10.1007/s10557-024-07647-0
- By:
- Publication type:
- Article
The Role of CTRP5 in Cardiovascular Disease: Friend or Foe?
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 7, doi. 10.1007/s10557-024-07640-7
- By:
- Publication type:
- Article
Gab1 in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 5, doi. 10.1007/s10557-024-07638-1
- By:
- Publication type:
- Article
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 9, doi. 10.1007/s10557-024-07630-9
- By:
- Publication type:
- Article
New Evidence on Diclofenac: Implications for Cardiovascular Safety.
- Published in:
- 2025
- By:
- Publication type:
- Letter to the Editor
Beta-blockers and Myocardial Infarction: to β -block or not to β -block.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 1, doi. 10.1007/s10557-024-07610-z
- By:
- Publication type:
- Article
Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial)
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 145, doi. 10.1007/s10557-024-07576-y
- By:
- Publication type:
- Article
Pharmacodynamic Drug-Drug Interactions and Bleeding Outcomes in Patients with Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants: a Nationwide Cohort Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 133, doi. 10.1007/s10557-023-07521-5
- By:
- Publication type:
- Article
Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 43, doi. 10.1007/s10557-023-07517-1
- By:
- Publication type:
- Article
Effect of Intensive Lipid-Lowering Therapy on Coronary Plaque Stabilization Derived from Optical Coherence Tomography: a Meta-analysis and Meta-regression.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 119, doi. 10.1007/s10557-023-07511-7
- By:
- Publication type:
- Article
Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 107, doi. 10.1007/s10557-023-07507-3
- By:
- Publication type:
- Article
Exercise Prevents Glucocorticoid-Induced Myocardial 4-Hydroxynonenal Production.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 165, doi. 10.1007/s10557-023-07506-4
- By:
- Publication type:
- Article
PDHA1 Alleviates Myocardial Ischemia-Reperfusion Injury by Improving Myocardial Insulin Resistance During Cardiopulmonary Bypass Surgery in Rats.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 17, doi. 10.1007/s10557-023-07501-9
- By:
- Publication type:
- Article
Beneficial Effects of Angiotensin II Receptor Blockers on Mortality in Patients with COVID-19: A Retrospective Study from 2019 to 2020 in China.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 63, doi. 10.1007/s10557-023-07494-5
- By:
- Publication type:
- Article
Evaluation of the Efficacy of Sacubitril/Valsartan on Radiofrequency Ablation in Patients with Hypertension and Persistent Atrial Fibrillation.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 97, doi. 10.1007/s10557-023-07493-6
- By:
- Publication type:
- Article
Advances in MicroRNA Therapy for Heart Failure: Clinical Trials, Preclinical Studies, and Controversies.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 221, doi. 10.1007/s10557-023-07492-7
- By:
- Publication type:
- Article
Effects of Rhythm Control for Atrial Fibrillation on Cardiac Remodeling and Valvular Regurgitation in Patients with Heart Failure.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 85, doi. 10.1007/s10557-023-07489-2
- By:
- Publication type:
- Article
US Population Eligibility and Estimated Impact of Semaglutide Treatment on Obesity Prevalence and Cardiovascular Disease Events.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 75, doi. 10.1007/s10557-023-07488-3
- By:
- Publication type:
- Article
Dexmedetomidine Alleviates Abdominal Aortic Aneurysm by Activating Autophagy Via AMPK/mTOR Pathway.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 33, doi. 10.1007/s10557-023-07483-8
- By:
- Publication type:
- Article
Sacubitril/Valsartan in Dialysis Patients: Update on Current Perspectives.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 187, doi. 10.1007/s10557-023-07481-w
- By:
- Publication type:
- Article
The Role of P53 in Myocardial Ischemia-Reperfusion Injury.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 195, doi. 10.1007/s10557-023-07480-x
- By:
- Publication type:
- Article
Netrin-1 and RGMa: Novel Regulators of Atherosclerosis-Related Diseases.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 211, doi. 10.1007/s10557-023-07478-5
- By:
- Publication type:
- Article
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 155, doi. 10.1007/s10557-023-07469-6
- By:
- Publication type:
- Article
Comparing Renin-Angiotensin-Aldosterone Blockade Regimens for Long-Term Chemotherapy-Related Cardiac Dysfunction: A Network Meta-Analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 171, doi. 10.1007/s10557-023-07457-w
- By:
- Publication type:
- Article